The effect of body size and change in BMI on endometrial cancer risk across different racial/ethnic groups has not been studied. We examined the association between body size and endometrial cancer risk and potential effect modification of other risk factors among 50,376 women in the Multiethnic Cohort Study. During 10.3 years of follow-up, 463 endometrial cancer cases were identified. Epidemiologic data were collected from the baseline questionnaire. ''BMI change'' was defined as the percentage of body mass index change from age 21 to the time of recruitment. Women who were heavier at age 21 or at baseline (weight ‡ 53.5 kg or ‡ 63.9 kg, respectively) had an increased endometrial cancer risk compared to the lowest quartile of weight during the respective periods. BMI gain ‡ 35% had a RR of 4.12 (95% CI: 2.69, 6.30) compared to the reference group (25% £ BMI change <15%). Women who averaged an annual BMI gain ‡ 1% had a >3.21-fold (95% CI: 2.37, 4.33) increased risk compared to women who maintained a stable adult BMI (20.25 to <10.25%). The highest risk associated with BMI gain was observed among nulliparous women and postmenopausal women who never used hormone therapy. Although African Americans and Whites showed an increase in risk after ‡35% BMI gain, Japanese Americans showed an increase in risk with much smaller gain ( ‡5%). In conclusion, adult obesity and increase in adiposity are risk factors for endometrial cancer; and the risk associated with these factors may vary across racial/ethnic groups. ' 
Endometrial cancer is the fourth most common cancer among US women. 1 The role of obesity in endometrial cancer etiology is well established 2, 3 ; prospective studies report obesity, defined as body mass index (BMI) 30 kg/m 2 , is associated with a 1.7-4.5 fold increase in risk. [4] [5] [6] [7] [8] [9] [10] [11] [12] Because substantial body weight gain can lead to obesity, it is believed that adult weight or BMI change, often a measure of increased adiposity, is associated with endometrial cancer risk.
Among 5 prospective studies, 5, 6, 8, 13, 14 all 5 reported a positive association between weight gain during the period of young adulthood (age, 18-25 years) to age at study entry and endometrial cancer risk; however, none of these studies have investigated the role of anthropometric measures across racial/ethnic populations. The aim of this analysis was to examine the association of body size and its change over time with the risk of endometrial cancer in a multiethnic population, as well as the potential modifying effect of other risk factors on these relations.
Material and methods

Study population
The Multiethnic Cohort Study (MEC) is a prospective cohort study established to investigate the association of lifestyle and genetic factors with chronic disease. Details of the study design, recruitment, response rates and baseline characteristics of the MEC have been previously published. 15 Briefly, the cohort consists of 215,251 men and women between the ages of 45-75 years selected from 5 racial/ethnic populations: African Americans, Japanese Americans, Latinos, Native Hawaiians, and Whites. Potential participants were identified through drivers' license files from the Department of Motor Vehicles, voter registration lists and Health Care Financing Administration data files primarily from Los Angeles County, California and the state of Hawaii during the period of 1993-1996. Initially, for the purpose of study recruitment, racial/ethnic groups were identified by last name but the final determinant of race/ethnicity was through self-report. The response rates were highest in Japanese Americans (51.3%), Whites (47.0%), and Native Hawaiians (42.2%) and lowest in African Americans (25.5%) and Latinos (21.3%). 15 Each participant completed a mailed self-administered questionnaire regarding demographic and lifestyle factors, physical activity, tobacco smoking history, diet, anthropometric measures, personal history of medical conditions, family history of cancer, and reproductive history and hormone use (women only). The respective institutional review boards have approved of the study protocol.
Inclusion and exclusion criteria
Women were excluded from the present analysis if they (i) were diagnosed with cancer (other than nonmelanoma skin cancer) before the date of the baseline questionnaire (n 5 6,734), (ii) had missing menopausal information or reported a hysterectomy or bilateral oophorectomy on the baseline questionnaire (n 5 19,656), (iii) had missing data on any of the following variables: education, height or weight at baseline, weight at age 21, age at menarche, age at menopause, parity, oral contraceptive (OC) use, postmenopausal hormone therapy (HT) use, smoking status and physical activity (n 5 12,117). After all exclusions, 50,376 eligible women (14.7% African Americans, 32.4% Japanese Americans, 18.7% Latinas, 8.1% Native Hawaiians and 26.2% Whites) were included in the analysis. Excluded women were approximately 3.5 years older than women retained for analysis, but the distribution of the remaining risk factors did not differ between the 2 groups.
Follow-up and case identification
Participants' follow-up time began at the completion of the baseline questionnaire and continued until they reach one of the following endpoints: (i) diagnosis of endometrial cancer, (ii) death or (iii) end of follow up (December 31, 2004) . All incident cases of endometrial cancer were identified through record linkage to the Hawaii Tumor Registry, the Cancer Surveillance Program for Los Angeles County and the California State Cancer Registry. These cancer registries participate in the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program and have completeness >99%. 16 Cases of endometrial cancer were defined by the International Classification of Diseases for Oncology (ICD-O-3) code C54 (uterine corpus). Uterine sarcomas (n 5 29) were excluded from the case group. Deaths within the cohort were determined through annual linkage to state death certificate files in California and Hawaii and periodically to the National Death Index. The follow-up rate in the cohort is 95%; National Death Index information was available for the remaining 5% of the cohort. Cohort participants were followed for an average 10.3 years, contributing to a total of 517,808 person-years of follow-up time. A total of 463 women with incident endometrial cancer were identified during the follow-up period.
Assessment of anthropometric measures
Measures of weight (at age 21 and baseline) and height (at baseline) were obtained by self-report from the baseline questionnaire. For cohort participants missing baseline weight data (6%), measures were imputed from their drivers' license files. The average correlation between self-reported weights (from questionnaire) and imputed weights (from drivers' license file) was 90%. If no source of information was available, participants were excluded from the analysis, as mentioned in the inclusion and exclusion criteria. The methodology of BMI (kg/m 2 ) calculations was previously reported. 17 Briefly, BMI at age 21 and at baseline was calculated using self-reported weights and height. To categorize BMI at baseline, we used cutpoints defined by World Health Organization standards. 18 Weight and height measures and BMI at age 21 were categorized according to quartile and tertile distributions of the eligible female population. We also examined all body size measures as continuous variables. Change in BMI (%) and change in weight (%) was calculated as [(measure at baseline minus measure at age 21)/measure at age 21] 3 100 and initially categorized using fine categories (intervals of 10% change); negative values denote loss, whereas positive values denote gain, and a value of ''0'' represents no change between reported body measure at age 21 to baseline. Percent change was used instead of absolute difference because it standardized the body weight variance of our study population. With regards to body size change over time, we opted to present percent BMI change instead of both weight and BMI change for the following reasons: (i) percent BMI change accounts for potential associations related to height; (ii) distribution and findings for BMI change and weight change were correlated (r 5 1.0) and nearly identical because there was only one measure of height. Average annual BMI change (%/year) was calculated as (change in BMI)/(age at cohort entry minus 21 years of age).
Statistical analysis
Relative risks (RR) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards models. Age (in days) was the underlying time variable in the Cox regression, starting with a participants' age at entry to one of the endpoints. For the main effects of anthropometric measures, Cox models were adjusted for the following variables: race/ethnicity (African American, Native Hawaiian, Japanese American, Latina and White), education (years), smoking status (never, past, current), age at menarche (12, (13) (14) 15) , menopausal status/age at natural menopause (premenopausal, <45, 45-49, 50-54, 55), parity (nulliparous, 1, 2-3, 4 children), duration/type of HT use (never and per 5 years of past estrogen only therapy (ET), past estrogenprogestin therapy (EPT), current ET and current EPT use), OC use (never, one month use), diabetes (yes, no) and hypertension (yes, no). For height, baseline weight in quartiles was added to the model and for percent BMI change, BMI at age 21 was adjusted for in the model. In addition, in our preliminary analyses, we included in our models factors related to energy balance: total caloric intake (continuous) and physical activity [measured in metabolic equivalents of energy expenditure (METs)]. 19, 20 We observed no change in our findings; therefore, we kept these variables out of the model. In an earlier study, we found differences in distribution of histological type 1 and 2 tumors by racial/ethnic groups primarily among African Americans. 9 We attempted to control for these differences by adjusting for race/ethnicity in our model; further exclusion of type 2 tumors from the analyses did not change our results.
Linear trend tests were conducted by treating the categorical variable of interest as continuous in the model. The likelihood ratio test was used to test for statistical interactions between menopausal status, ethnicity or BMI change and the covariates of interest with respect to endometrial cancer. The test compared the full model (main effect term and above mentioned covariates) to the full model including interaction terms. Interaction terms were created using the categories as described earlier. All statistical analyses were performed in SAS version 9.1 (SAS Institute, Cary, NC) and STATA version 10 (StataCorp, College Station, TX). Table I presents the baseline characteristics among eligible women by categories of BMI change. Overall, Japanese-American women had the least percentage BMI gain (<35%); whereas, African Americans and Latinas reported the greatest BMI gain (mean percent BMI change by racial/ethnic group: African Americans 5 36.0%, Japanese Americans 5 15.2%, Latinas 5 29.1%, Native Hawaiians 5 28.9% and Whites 5 21.3%). The majority of women (76.1%) were postmenopausal at cohort entry. Women who had a BMI loss or least amount of BMI gain (category 1) were more likely to be heavier at age 21, nulliparous, physically active, current HT users, and current smokers. Women with the greatest BMI gain (category 3) were more likely to be never HT users, have an earlier age at menarche, higher BMI at baseline and a history of diabetes and hypertension.
Results
The associations of anthropometric measures with endometrial cancer risk are shown in Table II . Compared to women in the lowest quartile of weight, at either age 21 or at baseline, women in both the third and fourth quartiles had an increase in endometrial cancer risk. BMI at age 21 21.897 kg/m 2 had a RR of 1.71 (95% CI: 1.31, 2.25), when compared to the lowest quartile. Women with a baseline BMI 30 kg/m 2 had a 3.5-fold increase in risk (95% CI: 2.70, 4.63) compared to those with a BMI < 25 kg/m 2 . A positive dose-response relation with BMI gain and the risk of endometrial cancer was observed, with a greater than 4-fold increased risk associated with 35% BMI gain (Table II) . When BMI at baseline (categorical, WHO criteria) was included in the model, the RRs were slightly attenuated toward the null (for 35% BMI gain: RR 5 2.60, 95% CI: 1.54, 4.39). For average annual BMI change, women who averaged a weight gain 0.5% per year had an increase in risk (>1.5-fold) compared to those with average annual change between 20.25 and <0.25%.
Measures of weight, BMI, and BMI change were associated with an increased risk of endometrial cancer in all racial/ethnic groups (Table III) . Because of the limited number of Native Hawaiian cases (n 5 44), we did not include them in this analysis. Japanese Americans had a greater than 4-fold risk at BMI 30 kg/m 2 . When using comparable categories, we found in Japanese Americans a smaller percentage of BMI gain (5%) was associated with endometrial cancer risk (RR 5 2.17; 95% CI: 1.29, 3.67). Because of few number of cases in African Americans and Latinas in the referent group (n 7), we also presented results using ethnic-specific tertiles. Among Latinas, endometrial cancer risk increased in those who gained 18.46% BMI from age 21 compared to their lowest tertile. Among Japanese Americans, a smaller increase in BMI (8.18 to <20.10%), was associated with endometrial cancer risk (RR 5 1.99; 95% CI: 1.25, 3.17), when compared to their lowest tertile group; whereas in Whites an association was not observed until BMI gain 26.19% and African Americans showed an increased risk only after a BMI gain 42.80%. Tests for heterogeneity showed weight at baseline, BMI change, and average annual BMI change in relation to endometrial cancer risk varied by ethnicity (p 5 0.002, 0.016 and 0.002, respectively); however, a significant difference was only observed for weight at baseline between Whites and African Americans (p 5 0.024) and between Whites and Japanese Americans (p 5 0.007).
We also explored the potential modifying effects of other endometrial cancer risk factors on the association of BMI change and endometrial cancer (Table IV) . The association between endometrial cancer and 35% BMI gain was strongest among women who never used HT (RR 5 5.33; 95% CI: 2.79, 10.2) or among nulliparous women (RR 5 7.05; 95% CI: 3.01, 16.5). The association between endometrial cancer and 35% adult weight gain was also stronger among nonsmokers (RR 5 4.27; 95% CI: 2.61, 6.99) than among either past or current smokers. Tests for interaction, however, was only notable for HT use (p < 0.001) and among nulliparous postmenopausal women (p 5 0.034, data not shown).
Discussion
In this large prospective multiethnic study, we confirmed that heavier weight and obesity (BMI 30 kg/m 2 ) increase endometrial cancer risk, as well as the presence of a dose-response relation with BMI. We also observed after adjusting for confounding variables, BMI at age 21 21.897 kg/m 2 and adult BMI gain increase risk. Risk was greatest among women who had a 35% gain in BMI or women who averaged 1% annual increase in BMI during the period from age 21 to cohort entry. Among Japanese Americans, a 5% gain in BMI resulted in increased risk of endometrial cancer.
The association of BMI gain and obesity with endometrial cancer might be explained by the unopposed estrogen theory which suggests that elevated exposures to estrogen, particularly when not counterbalanced by progesterone can result in increased mitotic proliferation of endometrial cells and greater likelihood for DNA replication errors and somatic mutations. 21 Obesity in postmenopausal women is associated with higher levels of circulating estrogens and lower levels of sex-hormone-binding globulins. 22 In premenopausal women, obesity results in chronic anovulation, a reduction of progesterone synthesis, and higher levels of free estrogen. 23 Five other prospective studies have investigated the association of weight or BMI gain with endometrial cancer risk. 5, 6, 8, 13, 14 Of which, Terry et al.
14 and Le Marchand et al. 13 found an association between weight change and endometrial cancer risk after adjusting for some comparable confounding variables to our study. In accord with our findings, Friedenreich et al., 6 Schouten et al. 5 and Chang et al.
8 observed a 1.75-fold increase in endometrial cancer risk among women in the highest category of weight or BMI change: 20 kg, 6 8 kg/m 2 , 5 (these 2 studies additionally adjusting for BMI at age 20) and 20 kg (additionally adjusting for weight at age 18 or baseline BMI). 8 When BMI at baseline was included in our model, the association between BMI gain and endometrial cancer was attenuated suggesting that the association may in part be explained by BMI at baseline. Prior studies found that current BMI was more predictive of endometrial cancer risk than earlier BMI measures. 6, 7, 13, 14, [24] [25] [26] Our findings from stratified analysis are in accordance with this hypothesis. Among those with the BMI at age 21 <19.35 kg/m 2 , a 35% BMI gain resulted in a 2-fold increased risk. However, among women in the second and highest tertiles of Among postmenopausal women only.
BMI at age 21, a 35% BMI gain resulted at least a 3-fold increased risk; perhaps because most women with very low BMI at age 21 do not gain enough weight to become overweight or obese later in life. Alternatively when stratified by baseline BMI, we found BMI gain is a risk factor for endometrial cancer, even when gain does not result in becoming overweight or obese (baseline BMI 25); suggesting both BMI gain and baseline BMI are risk factors for endometrial cancer development. Moreover, controlling for baseline BMI may possibly be an overadjustment because baseline BMI could be considered an intermediate 27 for BMI change, and in our population BMI change and BMI at baseline were highly correlated (r 5 0.74).
Prior studies [5] [6] [7] [8] 13, 14, 25, 26, 28, 29 have investigated the role of weight change on endometrial cancer risk using the absolute difference in weight or BMI. Only 2 case-control studies and no prospective studies examined percentage change (weight only) in relation to endometrial cancer risk. In both studies, the authors found a slightly 2-fold increase in risk among women with an adult weight gain 40%. 25, 28 We observed no change in our findings when using this measure of weight change.
In our study population, Japanese-American women had the least weight gain and African Americans the greatest weight gain in adulthood. Among Japanese Americans, who are leaner than women of other racial/ethnic groups to begin with, we found that a smaller percentage of BMI gain (5%) was associated with an increase in endometrial cancer risk, unlike the other 4 racial/ethnic groups, where a greater weight gain was needed to observe similar effects. To distinguish whether our findings may be associated with baseline BMI, we investigated the association between BMI at baseline and endometrial cancer risk, stratified by race/ethnicity and found Japanese Americans with a BMI 30 kg/m 2 had the greatest (4-fold) increase in endometrial cancer risk. Although our findings could be due to chance, they could also suggest that a lower percentage of BMI gain in Japanese-American women may result in sufficient hormonal changes to influence their endometrial cancer risk. It has been observed that Asians have a slightly higher body fat percentage than Whites with comparable BMI, 30 and that Japanese-American women relative to White women in the MEC have higher circulating levels of estrogens independent of BMI. RRs were adjusted for age, ethnicity, education, age at menarche, menopausal status, age at menopause, duration and type of hormone therapy, oral contraceptive use, parity, smoking history, diabetes, and hypertension.- To our knowledge, we are unaware of studies directly comparing the effect of BMI in endometrial or breast cancer incidence between Asians and Whites or other racial/ethnic groups. Studies specific to Asian populations showed conflicting findings regarding the role of BMI in endometrial cancer. In 2 case-control studies among Chinese women, one found BMI of 20.9-22.9 kg/m 2 or weight gain of 7.5 kg from ages 40-49 years to ages 50-59 years 32 to be associated with endometrial cancer; however, Xu et al. 28 , found an increase in risk only after a 30% weight gain. Because the majority of our Japanese-American population were born in the United States, it is possible the variation of lifestyle and dietary factors in American born Asians may contribute to this difference. In another hormone-obesity related cancer site, breast, Ziegler et al. 33 observed among Asian Americans in their 50s, weight gain of 11 lbs was associated with breast cancer. Moreover, a meta-analysis by Renehan et al. 34 found stronger associations in breast cancer risk per 5 kg/m 2 increase in BMI in postmenopausal women from the Asia-Pacific region than those from North American, European and Australian regions. Our findings in endometrial cancer risk by ethnicity merit corroboration in studies with larger sample size.
31
Consistent with results from 2 other prospective cohort studies, 6, 8 we found that postmenopausal HT modified the relation of weight gain to endometrial cancer risk; the risk associated with weight gain 35% was most apparent among never HT users, and was not observed in current ET or EPT users. It has been suggested that there is an upper limit beyond which unopposed estrogens do not induce further increase in the mitotic rate of endometrial cells. 23 ET use is a known and strong risk factor for endometrial cancer and thus the effect of weight gain is probably masked by its large effect on risk. For current EPT, it is possible that the added progestins counteract the effect of higher circulating estrogens from the increased adipose tissue mass. 23 In accordance with our findings, another prospective study found an increased incidence among nulliparous women with a BMI 30 kg/m 2 . 8 It has been previously observed that nullipar- 35 and FSH have been found to increase growth of endometrial cancer cell lines. 36 Thus, increased levels of FSH and estrogen as a result of nulliparity and BMI gain may play a multiplicative synergistic role in increasing endometrial cancer risk, particularly in postmenopausal women. Our findings should be corroborated in other studies.
There were some limitations in our study. Measures of height and weight were self-reported, possibly resulting in nondifferential misclassification. Nonetheless, such misclassification was not an important source of concern as some found self-reported height and weight are thought to be reasonably accurate 37 ; and women 50 years of age were observed to recall their body weight at age 18 with a correlation of 0.88 to actual measures taken. 38 However, differential misclassification as a result of self-perception or current weight 39 may play a factor in our findings. Selection bias as a result of varying response rates by racial/ethnic groups may limit external validity to general populations. Our estimation of average annual BMI change relies on the assumption that BMI or weight cycling does not play an important role in endometrial cancer risk; this association remains inconclusive. 7 Finally, our study would have benefited from additional measures of weight during followup period and/or measures of central adiposity, such as waist-tohip ratio that is reportedly a better predictor than BMI with regards to obesity-related diseases. 40 Additional weight measures closer to time of diagnosis would increase the predictability of risk modeling; however, if it is the case where recent weights or BMI gain measures are correlated with age stratums, we did not find a cohort effect within our population (data not shown). Strengths of the study include use of a prospective cohort design and the ability to control for a variety of potential confounders within a multiethnic population. Furthermore, measures of average annual BMI change in association with endometrial cancer risk may be beneficial to cancer prevention messaging. According to our findings, an average BMI increase of <0.5% per year, i.e. <5% per 10-year interval, does not increase endometrial cancer risk, thus weight control may be an effective means of reducing risk of endometrial cancer.
In conclusion, our results show that adult BMI gain is a risk factor for endometrial cancer. Risk from BMI gain may differ somewhat by racial/ethnic groups, particularly among Japanese Americans, where a smaller percentage BMI gain appears to increase risk. Finally, postmenopausal HT use and possibly parity modify endometrial cancer risk associated with adult BMI gain. The observed findings should be validated in other studies, and the role of genetic and other environmental factors as potential effect modifiers of BMI gain-related endometrial cancer risk should be evaluated as well. RRs were adjusted for age, ethnicity, education, age at menarche, menopausal status, age at menopause, duration and type of hormone therapy, oral contraceptive use, number of children, smoking history, BMI at age 21, diabetes, and hypertension.
